Search

Treatment of thoracic aortic rupture poses a substantial challenge for the aortic surgeon. The advent of thoracic endovascular aortic repair (TEVAR) revolutionized the treatment of this heterogeneous group of diseases. Some patients suitable for TEVAR, however, present severe peripheral vascular diseases that can prevent standard retrograde delivery of the stent graft through the femoral artery. In this report, we present a case series of 5 patients with thoracic aortic rupture successfully treated with cardiac transapical TEVAR.

4. Spotnitz W, Burks S. Use of tissue sealants in cardiac surgery. In: Franco K, Verrier E, editors. Advanced therapy in cardiac surgery. Hamilton, Ontario: BC Decker; 2003. p. 9-10. 5. Coselli JS, Bavaria JE, Fehrenbacher J, Stowe CL, Macheers SK, Gundry SR. Prospective randomized study of a protein-based tissue adhesive used as a hemostatic and structural adjunct in cardiac and vascular anastomotic repair procedures. J Am Coll Surg. 2003;197: 243-52; discussion 252-3. 6. Hewitt CW, Marra SW, Kann BR, Tran HS, Puc MM, Chrzanowski FA, et al. BioGlue surgical adhesive for thoracic aortic repair during coagulopathy: efficacy and histopathology. Ann Thorac Surg. 2000; 71:1609-12. 7. Raanani E, Latter DA, Errett LE, Bonneau DB, Leclerc Y, Salasidis